Source:http://linkedlifedata.com/resource/pubmed/id/10654982
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2000-2-15
|
pubmed:abstractText |
Intranasal corticosteroids are used widely for the treatment of allergic rhinitis because they are effective and well tolerated. However, their potential to suppress growth of pediatric subjects with allergic rhinitis continues to be a concern, particularly in light of reports of growth suppression after treatment with intranasal beclomethasone dipropionate or intranasal budesonide (see the article by Skoner et al in this month's issue). A 1-year study of prepubertal patients between 3 and 9 years of age with perennial allergic rhinitis was conducted to assess the effects on growth of mometasone furoate aqueous nasal spray (MFNS), a new once-daily (QD) intranasal corticosteroid with negligible bioavailability.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1098-4275
|
pubmed:author |
pubmed-author:BronskyE AEA,
pubmed-author:DamarajuC VCV,
pubmed-author:Mesarina-WickiBB,
pubmed-author:MillerS DSD,
pubmed-author:NolopK BKB,
pubmed-author:PearlmanD SDS,
pubmed-author:Ra?zA LAL,
pubmed-author:RooklinAA,
pubmed-author:RosenJ PJP,
pubmed-author:SchenkelE JEJ,
pubmed-author:SkonerD PDP,
pubmed-author:VandewalkerM LML,
pubmed-author:WandererAA
|
pubmed:issnType |
Electronic
|
pubmed:volume |
105
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
E22
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:10654982-Administration, Intranasal,
pubmed-meshheading:10654982-Anti-Inflammatory Agents,
pubmed-meshheading:10654982-Child,
pubmed-meshheading:10654982-Double-Blind Method,
pubmed-meshheading:10654982-Female,
pubmed-meshheading:10654982-Glucocorticoids,
pubmed-meshheading:10654982-Growth,
pubmed-meshheading:10654982-Growth Disorders,
pubmed-meshheading:10654982-Humans,
pubmed-meshheading:10654982-Male,
pubmed-meshheading:10654982-Pregnadienediols,
pubmed-meshheading:10654982-Rhinitis, Allergic, Perennial
|
pubmed:year |
2000
|
pubmed:articleTitle |
Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray.
|
pubmed:affiliation |
Valley Clinical Research Center, Easton, Pennsylvania 18045, USA. eschenkelm@aol.com
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Multicenter Study,
Clinical Trial, Phase III
|